|
1
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Binenbaum Y, Na'ara S and Gil Z:
Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug
Resist Updat. 23:55–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parvathaneni V, Kulkarni NS, Muth A and
Gupta V: Drug repurposing: A promising tool to accelerate the drug
discovery process. Drug Discov Today. 24:2076–2085. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pushpakom S, Iorio F, Eyers PA, Escott KJ,
Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et
al: Drug repurposing: Progress, challenges and recommendations. Nat
Rev Drug Discov. 18:41–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Apte MV, Haber PS, Darby SJ, Rodgers SC,
McCaughan GW, Korsten MA, Pirola RC and Wilson JS: Pancreatic
stellate cells are activated by proinflammatory cytokines:
Implications for pancreatic fibrogenesis. Gut. 44:534–541. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Apte MV, Wilson JS, Lugea A and Pandol SJ:
A starring role for stellate cells in the pancreatic cancer
microenvironment. Gastroenterology. 144:1210–1219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bachem MG, Schünemann M, Ramadani M, Siech
M, Beger H, Buck A, Zhou S, Schmid-Kotsas A and Adler G: Pancreatic
carcinoma cells induce fibrosis by stimulating proliferation and
matrix synthesis of stellate cells. Gastroenterology. 128:907–921.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bachem MG, Schneider E, Gross H,
Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A and
Adler G: Identification, culture, and characterization of
pancreatic stellate cells in rats and humans. Gastroenterology.
115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boj SF, Hwang CI, Baker LA, Chio II, Engle
DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, et al:
Organoid models of human and mouse ductal pancreatic cancer. Cell.
160:324–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koikawa K, Ohuchida K, Ando Y, Kibe S,
Nakayama H, Takesue S, Endo S, Abe T, Okumura T, Iwamoto C, et al:
Basement membrane destruction by pancreatic stellate cells leads to
local invasion in pancreatic ductal adenocarcinoma. Cancer Lett.
425:65–77. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Endo S, Nakata K, Ohuchida K, Takesue S,
Nakayama H, Abe T, Koikawa K, Okumura T, Sada M, Horioka K, et al:
Autophagy is required for activation of pancreatic stellate cells,
associated with pancreatic cancer progression and promotes growth
of pancreatic tumors in mice. Gastroenterology. 152:1492–1506.e24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sagara A, Nakata K, Yamashita T, Guan W,
Zhong P, Matsumoto S, Endo S, Iwamoto C, Shindo K, Ikenaga N, et
al: New high-throughput screening detects compounds that suppress
pancreatic stellate cell activation and attenuate pancreatic cancer
growth. Pancreatology. Apr 20–2021.(Epub ahead of print). doi:
10.1016/j.pan.2021.04.002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Özdemir BC, Pentcheva-Hoang T, Carstens
JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C,
Novitskiy SV, et al: Depletion of carcinoma-associated fibroblasts
and fibrosis induces immunosuppression and accelerates pancreas
cancer with reduced survival. Cancer Cell. 25:719–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao Y, Zhang H, Ma Q, Huang R, Lu J,
Liang X, Liu X, Zhang Z, Yu L, Pang J, et al: YAP1-mediated
pancreatic stellate cell activation inhibits pancreatic cancer cell
proliferation. Cancer Lett. 462:51–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jakubowska MA, Ferdek PE, Gerasimenko OV,
Gerasimenko JV and Petersen OH: Nitric oxide signals are
interlinked with calcium signals in normal pancreatic stellate
cells upon oxidative stress and inflammation. Open Biol.
6:1601492016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jahchan NS, Dudley JT, Mazur PK, Flores N,
Yang D, Palmerton A, Zmoos AF, Vaka D, Tran KQT, Zhou M, et al: A
drug repositioning approach identifies tricyclic antidepressants as
inhibitors of small cell lung cancer and other neuroendocrine
tumors. Cancer Discov. 3:1364–1377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marescal O and Cheeseman IM: Cellular
mechanisms and regulation of quiescence. Dev Cell. 55:259–271.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi E, Wang C, Fukazawa A, Taki M,
Sato Y, Sasaki T, Ueda M, Sasaki N, Higashiyama T and Yamaguchi S:
Environment-sensitive fluorescent probe: A benzophosphole oxide
with an electron-donating substituent. Angew Chemie Int Ed.
54:4539–4543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pampaloni F, Reynaud EG and Stelzer EHK:
The third dimension bridges the gap between cell culture and live
tissue. Nat Rev Mol Cell Biol. 8:839–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kozono S, Ohuchida K, Eguchi D, Ikenaga N,
Fujiwara K, Cui L, Mizumoto K and Tanaka M: Pirfenidone inhibits
pancreatic cancer desmoplasia by regulating stellate cells. Cancer
Res. 73:2345–2356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bynigeri RR, Jakkampudi A, Jangala R,
Subramanyam C, Sasikala M, Rao GV, Reddy DN and Talukdar R:
Pancreatic stellate cell: Pandora's box for pancreatic disease
biology. World J Gastroenterol. 23:382–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu LG, Packman LC, Weldon M, Hamlett J and
Rhodes JM: Protein phosphatase 2A, a negative regulator of the ERK
signaling pathway, is activated by tyrosine phosphorylation of
putative HLA class II-associated protein I (PHAPI)/pp32 in response
to the antiproliferative lectin, jacalin. J Biol Chem.
279:41377–41383. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janssens V and Goris J: Protein
phosphatase 2A: A highly regulated family of serine/threonine
phosphatases implicated in cell growth and signalling. Biochem J.
353:417–439. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Naetar N, Soundarapandian V, Litovchick L,
Goguen KL, Sablina AA, Bowman-Colin C, Sicinski P, Hahn WC,
DeCaprio JA and Livingston DM: PP2A-mediated regulation of ras
signaling in G2 is essential for stable quiescence and normal G1
length. Mol Cell. 54:932–945. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li L and Hanahan D: Hijacking the neuronal
NMDAR signaling circuit to promote tumor growth and invasion. Cell.
153:86–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arakaki AKS, Pan WA and Trejo JA: GPCRs in
cancer: Protease-activated receptors, endocytic adaptors and
signaling. Int J Mol Sci. 19:18862018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shiraishi Y, Natsume M, Kofuku Y, Imai S,
Nakata K, Mizukoshi T, Ueda T, Iwaï H and Shimada I:
Phosphorylation-induced conformation of β2-adrenoceptor
related to arrestin recruitment revealed by NMR. Nat Commun.
9:1942018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nieto Gutierrez A and McDonald PH: GPCRs:
Emerging anti-cancer drug targets. Cell Signal. 41:65–74. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cortes E, Sarper M, Robinson B, Lachowski
D, Chronopoulos A, Thorpe SD, Lee DA and Hernández AE: GPER is a
mechanoregulator of pancreatic stellate cells and the tumor
microenvironment. EMBO Rep. 20:e465562019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wiley SZ, Sriram K, Liang W, Chang SE,
French R, McCann T, Sicklick J, Nishihara H, Lowy AM and Insel PA:
GPR68, a proton-sensing GPCR, mediates interaction of
cancer-associated fibroblasts and cancer cells. FASEB J.
32:1170–1183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lappano R and Maggiolini M: G
protein-coupled receptors: Novel targets for drug discovery in
cancer. Nat Rev Drug Discov. 10:47–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Omary MB, Lugea A, Lowe AW and Pandol SJ:
The pancreatic stellate cell: A star on the rise in pancreatic
diseases. J Clin Invest. 117:50–59. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miyamoto H, Murakami T, Tsuchida K, Sugino
H, Miyake H and Tashiro S: Tumor-stroma interaction of human
pancreatic cancer: Acquired resistance to anticancer drugs and
proliferation regulation is dependent on extracellular matrix
proteins. Pancreas. 28:38–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Erkan M, Kleeff J, Gorbachevski A, Reiser
C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA and Friess
H: Periostin creates a tumor-supportive microenvironment in the
pancreas by sustaining fibrogenic stellate cell activity.
Gastroenterology. 132:1447–1464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Öhlund D, Handly-Santana A, Biffi G,
Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA,
Lee EJ, et al: Distinct populations of inflammatory fibroblasts and
myofibroblasts in pancreatic cancer. J Exp Med. 214:579–596. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu W, Tamim H, Shapiro S, Stang MR and
Collet JP: Use of antidepressants and risk of colorectal cancer: A
nested case-control study. Lancet Oncol. 7:301–308. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tegowski M, Fan C and Baldwin AS:
Thioridazine inhibits self-renewal in breast cancer cells via
DRD2-dependent STAT3 inhibition, but induces a G1 arrest
independent of DRD2. J Biol Chem. 293:15977–15990. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gwynne WD, Hallett RM, Girgis-Gabardo A,
Bojovic B, Dvorkin-Gheva A, Aarts C, Dias K, Bane A and Hassell JA:
Serotonergic system antagonists target breast tumor initiating
cells and synergize with chemotherapy to shrink human breast tumor
xenografts. Oncotarget. 8:32101–32116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Smith EML, Pang H, Cirrincione C,
Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C,
Le-Lindqwister N, et al: Effect of duloxetine on pain, function,
and quality of life among patients with chemotherapy-induced
painful peripheral neuropathy: A randomized clinical trial. JAMA.
309:1359–1367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirayama Y, Ishitani K, Sato Y, Iyama S,
Takada K, Murase K, Kuroda H, Nagamachi Y, Konuma Y, Fujimi A, et
al: Effect of duloxetine in Japanese patients with
chemotherapy-induced peripheral neuropathy: A pilot randomized
trial. Int J Clin Oncol. 20:866–871. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kajiwara I, Sano M, Ichimaru Y, Oshima Y,
Kitajima O, Hao H, Masamune A, Kim J, Ishii Y, Ijichi H, et al:
Duloxetine improves cancer-associated pain in a mouse model of
pancreatic cancer through stimulation of noradrenaline pathway and
its antitumor effects. Pain. 161:2909–2919. 2020. View Article : Google Scholar : PubMed/NCBI
|
